HopeStage
Back to all studies
CompletedNCT03019887

Antipsychotic Dose Reduction, Cognition, and Relapse in Schizophrenia

About this titleRead the official source — NCT03019887
Medication studyAges 20–70
The study in practice

Understand this study

Who was this study for?

Listed age limits: 20 years to 70 years.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateApril 2011
Recruitment status
Completed
Enrollment listed in the registry
139
Sponsor
Juntendo University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Locations
Not clearly listed
Age range
From 20 Years to 70 Years
Official registry ID
NCT03019887
Official title
Show the full official title

Correlation Between Cognitive Function and Relapse of Schizophrenia Regarding Dose Reduction in Patients Undergoing High-dose Antipsychotic Therapy

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Locations not listed

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Juntendo University, a university.

Who was this study for?

Listed age limits: 20 years to 70 years.

Want to explore more studies?

Explore studies